Literature DB >> 21745048

Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals.

Luis M Carcoba1, Arturo E Contreras, Antonio Cepeda-Benito, Mary W Meagher.   

Abstract

This study examined the effect of emotion on opiate withdrawal induced hyperalgesia to determine whether emotional states modulate the magnitude of hyperalgesia. One hundred Hispanic men were recruited into one of three groups: heroin withdrawal, long-term heroin abstinence, and control. Participants were presented with pictures to induce neutral, positive, and negative emotional states. Affective valence, arousal, pain threshold, and tolerance to ischemic pain were measured. When pain threshold and tolerance were compared, the withdrawal group displayed significant heightened pain sensitivity when negative affect was induced. The authors also found that former heroin addicts showed heightened pain sensitivity following months of abstinence.

Entities:  

Mesh:

Year:  2011        PMID: 21745048      PMCID: PMC3209757          DOI: 10.1080/10550887.2011.581985

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  62 in total

Review 1.  Vocalizations during withdrawal from opiates and cocaine: possible expressions of affective distress.

Authors:  Herbert E Covington; Klaus A Miczek
Journal:  Eur J Pharmacol       Date:  2003-04-25       Impact factor: 4.432

2.  Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise.

Authors:  W Maixner; R H Gracely; J R Zuniga; C B Humphrey; G R Bloodworth
Journal:  Am J Physiol       Date:  1990-12

3.  Affective associative learning modifies the sensory perception of nociceptive stimuli without participant's awareness.

Authors:  Annabel Wunsch; Pierre Philippot; Léon Plaghki
Journal:  Pain       Date:  2003-03       Impact factor: 6.961

4.  Individual differences in emotional processing and reactivity to pain among older women with rheumatoid arthritis.

Authors:  Nancy A Hamilton; Alex J Zautra; John Reich
Journal:  Clin J Pain       Date:  2007-02       Impact factor: 3.442

5.  Emotional modulation of pain: is it the sensation or what we recall?

Authors:  Fabio Godinho; Michel Magnin; Maud Frot; Caroline Perchet; Luis Garcia-Larrea
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

6.  Mechanical allodynia and thermal hyperalgesia upon acute opioid withdrawal in the neonatal rat.

Authors:  Sarah M Sweitzer; Caroline P Allen; Maurice H Zissen; Joan J Kendig
Journal:  Pain       Date:  2004-07       Impact factor: 6.961

7.  Pleasure into pain: the consequences of long-term opioid use.

Authors:  Jason M White
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

8.  Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype.

Authors:  Irmgard Tegeder; Jan Adolph; Helmut Schmidt; Clifford J Woolf; Gerd Geisslinger; Jörn Lötsch
Journal:  Eur J Pain       Date:  2008-04-18       Impact factor: 3.931

9.  Nervousness and pain sensitivity: II. Changed relation in ex-addicts as a predictor for early relapse.

Authors:  P M Liebmann; M Lehofer; M Moser; T Legl; G Pernhaupt; K Schauenstein
Journal:  Psychiatry Res       Date:  1998-06-02       Impact factor: 3.222

Review 10.  Pain genes.

Authors:  Tom Foulkes; John N Wood
Journal:  PLoS Genet       Date:  2008-07-25       Impact factor: 5.917

View more
  19 in total

1.  The affective dimension of pain as a risk factor for drug and alcohol addiction.

Authors:  Dana M LeBlanc; M Adrienne McGinn; Christy A Itoga; Scott Edwards
Journal:  Alcohol       Date:  2015-05-01       Impact factor: 2.405

Review 2.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

3.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

Review 4.  Opioid use disorder.

Authors:  John Strang; Nora D Volkow; Louisa Degenhardt; Matthew Hickman; Kimberly Johnson; George F Koob; Brandon D L Marshall; Mark Tyndall; Sharon L Walsh
Journal:  Nat Rev Dis Primers       Date:  2020-01-09       Impact factor: 52.329

Review 5.  Pharmacotherapeutic management of co-morbid alcohol and opioid use.

Authors:  Lauren E Hood; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Expert Opin Pharmacother       Date:  2020-02-27       Impact factor: 3.889

6.  Demographic and clinical factors predicting retention in methadone maintenance: results from an Irish cohort.

Authors:  C D Darker; J Ho; G Kelly; L Whiston; J Barry
Journal:  Ir J Med Sci       Date:  2015-05-31       Impact factor: 1.568

7.  Decision-making, somatic markers and emotion processing in opiate users.

Authors:  Kathryn Biernacki; Gill Terrett; Skye N McLennan; Izelle Labuschagne; Phoebe Morton; Peter G Rendell
Journal:  Psychopharmacology (Berl)       Date:  2017-10-23       Impact factor: 4.530

8.  Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement.

Authors:  Giovanni C Santoro; Joseph Carrion; Krishna Patel; Crystal Vilchez; Jennifer Veith; Jonathan D Brodie; Stephen L Dewey
Journal:  Neuropsychopharmacology       Date:  2017-04-10       Impact factor: 7.853

9.  Examining Relationships between Gender, Opioid Dependence, and Distress Tolerance among Patients in Substance Use Disorder Treatment.

Authors:  Matthew T Tull; Keith A Edmonds; Courtney N Forbes; Julia R Richmond; Jason P Rose; Michael D Anestis; Kim L Gratz
Journal:  Subst Use Misuse       Date:  2020-03-20       Impact factor: 2.164

10.  Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.

Authors:  Adam Kimbrough; Jenni Kononoff; Sierra Simpson; Marsida Kallupi; Sharona Sedighim; Kenia Palomino; Dana Conlisk; Jeremiah D Momper; Giordano de Guglielmo; Olivier George
Journal:  Psychopharmacology (Berl)       Date:  2020-02-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.